Does chemoradiotherapy after intended curative surgery increase survival of gastric cancer patients?
作者信息
Cuschieri A
机构信息
Department of Surgery and Molecular Oncology, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK.
出版信息
Gut. 2002 Jun;50(6):751. doi: 10.1136/gut.50.6.751.
Abstract
摘要
相似文献
1
Does chemoradiotherapy after intended curative surgery increase survival of gastric cancer patients?根治性手术后进行放化疗能否提高胃癌患者的生存率？
Gut. 2002 Jun;50(6):751. doi: 10.1136/gut.50.6.751.
2
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.手术和术前化疗后可切除胃癌的化疗与放化疗（CRITICS）：一项国际、开放标签、随机 3 期试验。
Lancet Oncol. 2018 May;19(5):616-628. doi: 10.1016/S1470-2045(18)30132-3. Epub 2018 Apr 9.
3
Chemoradiotherapy for patients with recurrent lymph-node metastasis or local recurrence of gastric cancer after curative gastrectomy.胃癌根治性切除术后出现复发性淋巴结转移或局部复发患者的放化疗。
Jpn J Radiol. 2016 Jan;34(1):35-42. doi: 10.1007/s11604-015-0502-6. Epub 2015 Nov 17.
4
Usefulness of chemoradiotherapy for inoperable gastric cancer.化疗放疗对不可切除胃癌的有效性
Ann R Coll Surg Engl. 2017 Apr;99(4):332-336. doi: 10.1308/rcsann.2016.0305. Epub 2016 Sep 23.
5
Survival after adjuvant chemoradiotherapy or surgery alone in resectable adenocarcinoma at the gastro-esophageal junction.胃食管结合部可切除腺癌术后辅助放化疗或单纯手术的生存情况。
Scand J Surg. 2012;101(1):26-31. doi: 10.1177/145749691210100106.
6
Postoperative carcinoembryonic antigen level has a prognostic value for distant metastasis and survival in rectal cancer patients who receive preoperative chemoradiotherapy and curative surgery: a retrospective multi-institutional analysis.术后癌胚抗原水平对接受术前放化疗及根治性手术的直肠癌患者的远处转移及生存具有预后价值：一项多机构回顾性分析。
Clin Exp Metastasis. 2016 Dec;33(8):809-816. doi: 10.1007/s10585-016-9818-6. Epub 2016 Aug 23.
7
Effect of rescue surgery after non-curative endoscopic resection of early gastric cancer.早期胃癌内镜切除术后补救性手术的效果。
Br J Surg. 2015 Oct;102(11):1394-401. doi: 10.1002/bjs.9873. Epub 2015 Aug 27.
8
Gastric cancer and adjuvant chemoradiotherapy: when and where, that's the question.胃癌与辅助放化疗：何时何地进行，这才是问题所在。
J BUON. 2011 Jul-Sep;16(3):473-7.
9
A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.一项关于D2切除的胃癌患者辅助性S-1/顺铂化疗后再进行基于S-1的同步放化疗的II期研究。
Cancer Chemother Pharmacol. 2016 Mar;77(3):605-12. doi: 10.1007/s00280-016-2973-2. Epub 2016 Feb 5.
10
Comparison of curative surgery and definitive chemoradiotherapy as initial treatment for patients with cervical esophageal cancer.根治性手术与根治性放化疗作为颈段食管癌患者初始治疗的比较
Dis Esophagus. 2017 Feb 1;30(2):1-5. doi: 10.1111/dote.12502.
引用本文的文献
1
Development of a reliable surgical quality assurance tool for gastrectomy in oncological trials.开发一种用于肿瘤临床试验中胃切除术的可靠手术质量保证工具。
Gastric Cancer. 2024 Jul;27(4):876-883. doi: 10.1007/s10120-024-01503-8. Epub 2024 May 18.
2
What can we learn from oncology surgical trials?我们能从肿瘤外科临床试验中学到什么？
Nat Rev Clin Oncol. 2016 Jan;13(1):55-62. doi: 10.1038/nrclinonc.2015.176. Epub 2015 Oct 20.
3
Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study.胃癌根治术后复发的预测：一项前瞻性多中心研究得出的评分系统
Ann Surg. 2005 Feb;241(2):247-55. doi: 10.1097/01.sla.0000152019.14741.97.
本文引用的文献
1
Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study.淋巴结阳性胃癌患者胃切除术后的辅助化疗：一项多中心随机研究。
Br J Cancer. 1996 Feb;73(4):549-52. doi: 10.1038/bjc.1996.95.
Zotero 插件